Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients

被引:54
|
作者
Wen, Shi-Rong [2 ]
Liu, Guo-Jun [2 ]
Feng, Ren-Nan [3 ]
Gong, Feng-Chao [2 ]
Zhong, Hua [2 ]
Duan, Shu-Rong [2 ]
Bi, Sheng [1 ,2 ]
机构
[1] Harbin Med Coll, Cent Lab, Affiliated Hosp 1, Harbin 150001, Peoples R China
[2] Harbin Med Coll, Dept Neurol, Affiliated Hosp 1, Harbin 150001, Peoples R China
[3] Harbin Med Coll, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin 150001, Peoples R China
关键词
Osteopontin; IL-23; Multiple sclerosis; DENDRITIC CELLS; MESSENGER-RNA; PATHOGENESIS; EXPRESSION; CORRELATE; DISEASE;
D O I
10.1016/j.jneuroim.2011.12.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Osteopontin (OPN) and interleukin-23 (IL-23) are pro-inflammatory cytokines proposed to play central roles to the development of multiple sclerosis (MS). The aim of this study was to evaluate levels of OPN, IL-23 and other inflammatory cytokines and investigate their relationships in serum and cerebrospinal fluid (CSF) in patients with MS. Fifty one MS patients and 48 patients with non-inflammatory neurological diseases (NIND) were recruited from clinic. The levels of OPN, IL-23, IL-17, IL-6, and tumor necrosis factor-alpha (TNF-alpha) in serum and CSF were determined in each participant. Compared with NIND group, MS patients had significantly elevated levels of OPN, IL-23, IL-17 and TNF-alpha in CSF, and elevated levels of IL-23, IL-17 and TNF-alpha in serum (All P<0.001). In MS patients, OPN and IL-23 were positively correlated with IL-17 (r = 0.302, P=0.019; r = 0.417, P=0.001, respectively); and IL-23 was positively correlated with EDSS (r = 0.329, P=0.019). Both OPN and IL-23 may play pivotal role in development of MS and might be specific markers and therapeutic targets for MS. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:94 / 96
页数:3
相关论文
共 50 条
  • [41] Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis
    Nakashima, I
    Fujihara, K
    Misu, T
    Okita, N
    Takase, S
    Itoyama, Y
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 111 (1-2) : 64 - 67
  • [42] Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients
    Bartova, Radka
    Petrlenicova, Darina
    Oresanska, Katarina
    Prochazkova, Lubica
    Liska, Branislav
    Turecky, Ladislav
    Durfinova, Monika
    NEUROENDOCRINOLOGY LETTERS, 2016, 37 (02) : 102 - 106
  • [43] Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis
    Brettschneider, J
    Maier, M
    Arda, S
    Claus, A
    Süssmuth, SD
    Kassubek, J
    Tumani, H
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (03) : 261 - 265
  • [44] Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients
    Vogt, MHJ
    Floris, S
    Killestein, J
    Knol, DL
    Smits, M
    Barkhof, F
    Polman, CH
    Nagelkerken, L
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 155 (1-2) : 155 - 160
  • [45] Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica
    Farrokhi, Mehrdad
    Rezaei, Ali
    Amani-Beni, Ali
    Etemadifar, Masoud
    Kouchaki, Ebrahim
    Zahedi, Abolfazl
    ACTA NEUROLOGICA BELGICA, 2015, 115 (04) : 609 - 614
  • [46] Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients
    Yuceyar, N
    Taskiran, D
    Sagduyu, A
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2001, 103 (04) : 206 - 211
  • [47] Irisin levels in the serum and cerebrospinal fluid of patients with multiple sclerosis and the expression and distribution of irisin in experimental autoimmune encephalomyelitis
    Zhang, Qiu-Xia
    Zhang, Sheng-Nan
    Zhang, Lin-Jie
    Zhang, Da-Qi
    Yang, Li
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 206 (02) : 208 - 215
  • [48] Soluble L-selectin levels in serum and cerebrospinal fluid in patients with multiple sclerosis and systemic lupus erythematosus
    Baraczka, K
    Pozsonyi, T
    Nékám, K
    Virányi, M
    Seszták, M
    Szongoth, M
    Jakab, L
    ACTA NEUROLOGICA SCANDINAVICA, 2000, 102 (02): : 114 - 117
  • [49] Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis
    Harris, Violaine K.
    Diamanduros, Andrew
    Good, Pamela
    Zakin, Elina
    Chalivendra, Varun
    Sadiq, Saud A.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 331 - 339
  • [50] Identification of Biomarkers in Cerebrospinal Fluid and Serum of Multiple Sclerosis Patients by Immunoproteomics Approach
    Colomba, Paolo
    Fontana, Simona
    Salemi, Giuseppe
    Barranca, Marilisa
    Lo Sicco, Claudia
    Mazzola, Maria Antonietta
    Ragonese, Paolo
    Savettieri, Giovanni
    De Leo, Giacomo
    Alessandro, Riccardo
    Duro, Giovanni
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (12): : 23269 - 23282